Novo Holdings to acquire Altasciences
Edgemont Partners served as co-advisor to Altasciences
Edgemont Partners is a premier healthcare investment bank that provides merger and acquisition advisory and growth capital raising services exclusively for healthcare companies. With deep domain expertise, exceptional execution, and incomparable integrity we go beyond the fundamentals to secure the greatest value and optimal overall terms for your company.
Right from the start, the Edgemont team demonstrated a strong understanding of the Emergency Medicine business and a real commitment to providing great service and the right advice. Edgemont’s market insight and strong execution resulted in a great transaction for FEP’s shareholders, with a partner that will provide the tools and resources to better serve the emergency medicine needs of Orlando. Edgemont’s professionalism and dedication to this engagement, and the depth of its industry experience, resulted in a competitive process that brought us an outstanding partner.
Edgemont has been an exceptional partner and key element to our success. Their strategic insights, industry knowledge, and transaction execution expertise proved invaluable to ERG’s formation, growth, and value creation, and in supporting us to build an industry-leading model for clinical research site services to facilitate improved drug development services for our biopharmaceutical and CRO clients. Edgemont’s M&A expertise in pharmaceutical services and the clinical research site services market in particular is beyond compare, and their commitment to ERG and our success exceeded our expectations.
We chose Edgemont for their deep healthcare expertise, comprehensive knowledge of the buyer universe and strong execution capabilities. In addition to their M&A expertise in post-acute care services, the Edgemont team is adept at navigating the hot button issues for both buyers and sellers while maintaining focus on delivering a successful transaction. Their team managed a rigorous process under a tight timeline and helped to secure the best buyer for our company, ultimately delivering a strong outcome for the Board and shareholders.
The rapidly growing outsourced life science services market is consolidating at an accelerating rate, driving PE / VC…
Interest in urology is accelerating with a growing number of new platforms seeking consolidation opportunities and a highly…